These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 7881050
1. Modulation of striatal aspartate and dynorphin B release by cholecystokinin (CCK-8) studied in vivo with microdialysis. You ZB, Pettersson E, Herrera-Marschitz M, Hökfelt T, Terenius L, Nylander I, Goiny M, Hughes J, O'Connor WT, Ungerstedt U. Neuroreport; 1994 Nov 21; 5(17):2301-4. PubMed ID: 7881050 [Abstract] [Full Text] [Related]
2. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes. You ZB, Godukhin O, Goiny M, Nylander I, Ungerstedt U, Terenius L, Hökfelt T, Herrera-Marschitz M. Naunyn Schmiedebergs Arch Pharmacol; 1997 May 21; 355(5):576-81. PubMed ID: 9151295 [Abstract] [Full Text] [Related]
3. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity. You ZB, Herrera-Marschitz M, Pettersson E, Nylander I, Goiny M, Shou HZ, Kehr J, Godukhin O, Hökfelt T, Terenius L, Ungerstedt U. Neuroscience; 1996 Oct 21; 74(3):793-804. PubMed ID: 8884775 [Abstract] [Full Text] [Related]
4. Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain. Ge J, Long SK, Kilpatrick IC. Eur J Pharmacol; 1998 Mar 19; 345(2):163-70. PubMed ID: 9600632 [Abstract] [Full Text] [Related]
5. Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats. You ZB, Herrera-Marschitz M, Nylander I, Goiny M, Kehr J, Ungerstedt U, Terenius L. Brain Res; 1996 Feb 26; 710(1-2):241-8. PubMed ID: 8963665 [Abstract] [Full Text] [Related]
6. Effect of local cholecystokinin-8 administration on extracellular levels of amino acids and glycolytic products monitored by in vivo microdialysis in the fronto-parietal cortex of the rat. Godukhin O, You ZB, Herrera-Marschitz M, Goiny M, Pettersson E, Hökfelt T, Ungerstedt U. Neurosci Lett; 1995 Jul 14; 194(1-2):29-32. PubMed ID: 7478205 [Abstract] [Full Text] [Related]
7. Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis. You ZB, Saria A, Fischer-Colbrie R, Terenius L, Goiny M, Herrera-Marschitz M. Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec 14; 354(6):717-24. PubMed ID: 8971731 [Abstract] [Full Text] [Related]
8. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists. You ZB, Herrera-Marschitz M, Nylander I, Goiny M, O'Connor WT, Ungerstedt U, Terenius L. Neuroscience; 1994 Nov 14; 63(2):427-34. PubMed ID: 7891856 [Abstract] [Full Text] [Related]
10. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--I. Effects of K(+)-depolarization, lesions and peptidase inhibition. You ZB, Nylander I, Herrera-Marschitz M, O'Connor WT, Goiny M, Terenius L. Neuroscience; 1994 Nov 14; 63(2):415-25. PubMed ID: 7891855 [Abstract] [Full Text] [Related]
11. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function. Morari M, O'Connor WT, Ungerstedt U, Bianchi C, Fuxe K. Neuroscience; 1996 May 14; 72(1):89-97. PubMed ID: 8730708 [Abstract] [Full Text] [Related]
12. On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis. Herrera-Marschitz M, You ZB, Goiny M, Meana JJ, Silveira R, Godukhin OV, Chen Y, Espinoza S, Pettersson E, Loidl CF, Lubec G, Andersson K, Nylander I, Terenius L, Ungerstedt U. J Neurochem; 1996 Apr 14; 66(4):1726-35. PubMed ID: 8627331 [Abstract] [Full Text] [Related]
13. Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain. Boden PR, Woodruff GN, Pinnock RD. Br J Pharmacol; 1991 Mar 14; 102(3):635-8. PubMed ID: 1364831 [Abstract] [Full Text] [Related]
14. On the origin of striatal cholecystokinin release: studies with in vivo microdialysis. You ZB, Herrera-Marschitz M, Brodin E, Meana JJ, Morino P, Hökfelt T, Silveira R, Goiny M, Ungerstedt U. J Neurochem; 1994 Jan 14; 62(1):76-85. PubMed ID: 7903356 [Abstract] [Full Text] [Related]
15. Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat. Bustamante D, You ZB, Castel MN, Johansson S, Goiny M, Terenius L, Hökfelt T, Herrera-Marschitz M. J Neurochem; 2002 Nov 14; 83(3):645-54. PubMed ID: 12390526 [Abstract] [Full Text] [Related]
16. Cholecystokinin-8 increases K(+)-evoked [3H] gamma-aminobutyric acid release in slices from various brain areas. Pérez de la Mora M, Hernandez-Gómez AM, Méndez-Franco J, Fuxe K. Eur J Pharmacol; 1993 Dec 21; 250(3):423-30. PubMed ID: 8112402 [Abstract] [Full Text] [Related]
17. Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides. You ZB, Herrera-Marschitz M, Terenius L. J Pharmacol Exp Ther; 1999 Sep 21; 290(3):1307-15. PubMed ID: 10454508 [Abstract] [Full Text] [Related]